2 weeks Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week’s Release Zacks X
2 weeks ARS Pharmaceuticals’ Neffy Launch Could Be A Hit For Severe Allergic Reactions Seeking Alpha X
3 weeks Unlocking Q4 Potential of Vertex (VRTX): Exploring Wall Street Estimates for Key Metrics Zacks X
3 weeks Regeneron Pharmaceuticals Beats On Libtayo’s Back, Unveils Dividend Investor's Business Daily X
3 weeks Regeneron’s earnings boosted by more than doubling of U.S. sales of blockbuster eye drug Eylea MarketWatch X
3 weeks Wall Street Analysts Predict a 27.12% Upside in Amneal (AMRX): Here’s What You Should Know Zacks X
3 weeks Zentalis Pharmaceuticals (ZNTL) Loses -46.3% in 4 Weeks, Here’s Why a Trend Reversal May be Around the Corner Zacks X
3 weeks How Painkillers Could Be Vertex Pharmaceuticals’ Next $10 Billion Chapter Investor's Business Daily X
3 weeks Vertex Pharmaceuticals CEO on non-opioid painkiller: It’s safe, effective and non-addictive YouTube X
3 weeks Vertex Pharmaceuticals stock is soaring. The FDA just approved its potentially game-changing pain treatment. MarketWatch X
3 weeks Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller Investor's Business Daily X
4 weeks Vertex Pharmaceuticals (VRTX) Stock Slides as Market Rises: Facts to Know Before You Trade Zacks X
4 weeks Eledon Pharmaceuticals: At The Forefront Of The Organ Transplant Management Business Seeking Alpha X
4 weeks Wall Street Analysts Think Rhythm Pharmaceuticals (RYTM) Could Surge 26.36%: Read This Before Placing a Bet Zacks X
4 weeks Trump calls for tariffs on computer chips, semiconductors and pharmaceuticals from Taiwan VentureBeat X
4 weeks Here’s What Could Help Eton Pharmaceuticals (ETON) Maintain Its Recent Price Strength Zacks X
1 month Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength? Zacks X
1 month BioMarin Pharmaceuticals: Share Downdraft Combined With VOXZOGO Potential Makes A Buy Seeking Alpha X